Company news

22nd Century Group, Inc news in 2022

22nd Century Group, Inc's news releases, calls and decks from 2022, newest first.

View company

22nd Century Group Provides Update on Grass Valley Facility

December 7, 2022

22nd Century Group Provides Update on Incident at Grass Valley Facility

November 20, 2022

22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands

November 15, 2022

22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022

November 7, 2022

22nd Century Group (Nasdaq: XXII) to Announce Third Quarter 2022 Results on November 8, 2022

October 26, 2022

22nd Century Group (Nasdaq: XXII) to Expand VLN® Sales in Three Additional States: Arizona, Utah and New Mexico

October 25, 2022

22nd Century Group (Nasdaq: XXII) Expands VLN® Distributor Network with the Addition of Specialty Distributor Creager Mercantile

October 2, 2022

22nd Century Group (Nasdaq: XXII) Partners With Eagle Rock Distributing Company to Place VLN® in Thousands of Retail Locations Across Colorado

September 19, 2022

22nd Century Group’s (Nasdaq: XXII) VLN® Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden’s Cancer Moonshot Initiative

September 12, 2022

22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board

September 11, 2022

22nd Century Group (Nasdaq: XXII) Launches VLN® Reduced Nicotine Content Cigarettes in Colorado with Circle K, Smoker Friendly and New Distribution Points

September 6, 2022

22nd Century Group (Nasdaq: XXII) Announces Management Updates and Departure of Chief Operating Officer

September 6, 2022

22nd Century Group (Nasdaq: XXII) VLN® Reduced Nicotine Content Cigarettes Awarded Best New Product by Convenience Store News

August 23, 2022

22nd Century Group (Nasdaq: XXII) to Ring the Nasdaq Stock Market Closing Bell

August 21, 2022

22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022

August 8, 2022

22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2022 Results on August 9, 2022

July 26, 2022

22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules

July 20, 2022

22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO

June 15, 2022

22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business

May 22, 2022

22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform

May 17, 2022

22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company

May 12, 2022

22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022

May 4, 2022

22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders

April 27, 2022

22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022

April 13, 2022

22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer

April 10, 2022

22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2021

February 28, 2022

22nd Century Group Announces South Korea as First VLN® International Market

February 27, 2022

22nd Century Secures USDA Organic Certification for Needle Rock Farms

February 9, 2022

22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022

February 2, 2022

22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale

January 25, 2022

22nd Century Group Appoints James A. Mish to Its Board of Directors

January 20, 2022

22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less

January 17, 2022

Calls in 2022

Decks in 2022